Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Bladder cancer--what's new].

× No keyword cloud information.

15 in total

1. New HIV-drug inhibits in vitro bladder cancer migration and invasion.

Authors: M Retz; S S Sidhu; J Lehmann; H Tamamura; N Fujii; C Basbaum
Journal: Eur Urol Date: 2005-08-15 Impact factor: 20.096

2. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.

Authors: Dieter Jocham; Fred Witjes; Sigrid Wagner; Bram Zeylemaker; Jeroen van Moorselaar; Marc-Oliver Grimm; Rolf Muschter; Gralf Popken; Frank König; Ruth Knüchel; Karl-Heinz Kurth
Journal: J Urol Date: 2005-09 Impact factor: 7.450

3. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.

Authors: Achim Fleischmann; George N Thalmann; Regula Markwalder; Urs E Studer
Journal: J Clin Oncol Date: 2005-04-01 Impact factor: 44.544

4. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Authors:
Journal: Eur Urol Date: 2005-04-25 Impact factor: 20.096

5. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).

Authors: Jan Lehmann; Margitta Retz; Christina Wiemers; Joachim Beck; Joachim Thüroff; Christoph Weining; Peter Albers; Detlef Frohneberg; Tanja Becker; Peter-Jörg Funke; Peter Walz; Sigrun Langbein; Frank Reiher; Matthias Schiller; Kurt Miller; Stephan Roth; Tilman Kälble; Donald Sternberg; Stefan Wellek; Michael Stöckle
Journal: J Clin Oncol Date: 2005-06-06 Impact factor: 44.544

6. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.

Authors: Toshifumi Kurahashi; Isao Hara; Nobutoshi Oka; Sadao Kamidono; Hiroshi Eto; Hideaki Miyake
Journal: Clin Cancer Res Date: 2005-05-15 Impact factor: 12.531

7. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

Authors: Theo M de Reijke; Karl Heinz Kurth; Richard J Sylvester; Reg R Hall; Maurizio Brausi; Kees van de Beek; K E J Landsoght; Paul Carpentier
Journal: J Urol Date: 2005-02 Impact factor: 7.450

[Bladder cancer--what's new].